1421372-66-8
- Product Name：Mutated EGFR-IN-1(Osimertinib Intermediate)
- Molecular Formula：C25H31N7O
- Purity：99%
- Molecular Weight：445.56
Product Details:
CasNo： 1421372-66-8
Molecular Formula： C25H31N7O
Appearance： Yellow to brown solid
Packing： Aluminium bag
Throughput： 100KG/Month
Purity： 99%
Mutated EGFR-IN-1 serves as an important synthetic intermediate in the manufacturing route of Osimertinib, a third-generation irreversible EGFR tyrosine kinase inhibitor for non-small cell lung cancer.
Rigorous quality control on chemical purity, related substances, moisture, residual solvents and heavy metals is essential at this intermediate stage, as impurity profiles of this precursor will be carried forward and directly affect the final Osimertinib API quality.
The product is supplied for pharmaceutical process development, route optimization and commercial synthesis of Osimertinib. It is not an active pharmaceutical ingredient, not a finished drug, and for synthetic use only, not for human administration.
Relevant Products
-
ApixabanCAS：503612-47-3
-
Gabapentin EnacarbilCAS：478296-72-9
-
XanomelineCAS：131986-45-3
